Disclaimer: This article was published in 2021 and reflects the information available at that time.
  The PDL Professional Officers have noted a recent reduction in the number of calls about the COVID-19 vaccination service. This is pleasing and a likely indication of reduced demands on pharmacists and a greater familiarity with the vaccination process. However, this phase of the pharmacy vaccination service brings other challenges. With the inclusion of the Pfizer Comirnaty vaccine into the pharmacy vaccination program, there are increased risks that need to be identified and managed by pharmacists and pharmacy owners. Managing three brands of vaccine Handling three different…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Professional Indemnity cover for pharmacy students
21 April 2026
NationalIncident managementRegulatory and compliancePractice support, tips and tools
Learn more
Communication matters
16 April 2026
NationalNSWLeadership and communicationIncident managementPractice support, tips and tools
Learn more
Professional Indemnity Insurance – what hospital pharmacists need to know
1 April 2026
National
Learn more